Hakim Hammach, PhD, MBA

Hakim Hammach, PhD, MBA

Position: Vice President, Business Development

Dr. Hakim Hammach joined Geneos as the Vice President of Business Development, bringing with him over 20 years of leadership experience as a venture capital investor in health and life sciences, a strategy consultant for pharmaceutical and biotech companies, and a drug discovery scientist. He previously served as an advisor to early stage investors to identify investment opportunities and grow their portfolio in life sciences. Prior to joining Geneos,  Dr. Hammach led the investment team at Riyadh Valley Company (RVC), as the Managing Director of Investments, from its founding in 2010 to 2018. At RVC he led multiple successful investments in emerging biotech/life science companies through deal initiation, diligence, structuring, board engagement, and exit – including notably, investments in Avidity Biosciences (NASDAQ: RNA) and Prokarium.

Previously, Dr. Hammach served as Senior Strategy Consultant with Accenture, providing growth strategy and management consulting services to large Pharmaceutical and Biotech Companies in the US and Europe.  While at Accenture, his engagements focused on M&A, business development strategy, and R&D portfolio evaluation/prioritization. He was a Duke Venture Fellow with Aurora Funds where he served with the Life Science and Healthcare Investment team. Dr. Hammach was a Principal Scientist with Boehringer Ingelheim Pharmaceuticals (BIPI) where he led several drug discovery programs in the area of immunology and inflammation. Under Dr. Hammach’s leadership, his teams advanced several programs to the clinical development stage.

Dr. Hammach served as a Postdoctoral fellow at the University of Pennsylvania after having earned a Ph.D. in Chemistry from the University of Vermont. In addition, he holds a MBA from Duke University, Fuqua School of Business. He is an inventor with 18 issued US patents and has co-authored numerous scientific articles in leading international journals.